anti inflammatory/obesity

The present invention relates to the field of bioorgmic chemistry and concerns N-acyl derivatives of amino acids and pharmaceutically acceptable salts thereof, novel processes for synthesis of said compounds as well as pharmaceutical compositions based on them and use thereof in medicine as

The present invention relates to the field of bioorganic chemistry and concerns N-acyl derivatives of amino acids and pharmaceutically acceptable salts thereof, novel processes for synthesis of said compounds as well as pharmaceutical compositions based on them and use thereof in medicine as

FIELD OF INVENTION The present invention relates to compositions and methods for preventing and treating diseases related to metabolic and stress-related disorders and environmentally induced health disorders. More specifically, the invention relates to compositions enriched in phytochemicals having

FIELD OF INVENTION This invention relates generally to the new phytochemical compositions for reducing or preventing mammalian obesity. In particular, the invention relates to novel, synergistic compositions comprising enriched demethylated curcuminoids, extract of Moringa oleifera, extract of

FIELD OF THE INVENTION The invention relates to a probiotic and a composition comprising the same. Particularly, the invention relates to a new lactic acid bacteria and its use in enhancing immunomodulatory and anti-inflammatory activity. BACKGROUND OF THE INVENTION Fermented food products contain

FIELD OF INVENTION The invention relates to development of drugs to treat metabolic syndrome targeting components of the complex pathophysiology. BACKGROUND OF THE INVENTION Metabolic diseases in general and Type II diabetes [(T2DM or T2D or Type II Diabetes or Non-insulin dependent mellitus

BACKGROUND OF THE INVENTION The present invention relates to compounds that are melanocortin receptor agonists, to the preparation thereof and to the therapeutic use thereof. Melanocortin receptors (MC-Rs) belong to the superfamily of G protein-coupled seven-transmembrane domaine receptors. Their

TECHNICAL FIELD The present invention relates to novel biaryl derivatives as GPR120 agonists, a method for preparing the same, a pharmaceutical composition comprising the same as active components and use thereof. Herein a GPR120 agonist means a compound which can be effectively used for preventing

TECHNICAL FIELD The present invention relates to novel thioaryl derivatives as GPR120 agonists, a method for preparing the same, a pharmaceutical composition comprising the same and use thereof. Herein a GPR120 agonist means a compound which can be effectively used for preventing or treating

This application is a 371 U.S. National Phase Entry of pending International Application No. PCT/US2014/036644, filed May 2, 2014, which claims priority to U.S. Pat. Appl. Ser. No. 61/818,753, filed May 2, 2013, each of which is incorporated herein by reference in its entirety. FIELD OF

This application is a CON of PCT/JP2006/302058, filed Feb. 7, 2006. TECHNICAL FIELD OF THE INVENTION The present invention relates to adiponectin inducers or secretagogues, and preventive/therapeutic agents of various diseases by making use of the secretagogue or inducer of adiponectin. More

BACKGROUND OF THE INVENTION The present invention relates to novel xanthone derivatives, a process of preparing the same, pharmaceutical compositions comprising the same, and their use as pharmaceuticals, hair growth promotion agents, weight reduction and anti-obesity agents, and anti-inflammatory

This invention relates to a family of fluorinated aryl, heteroaryl, O-aryl and O-heteroaryl glycoside compounds, the process for their preparation, as well as the application of same in the pharmaceutical or cosmetic fields, in particular for the treatment or prevention of diabetes and obesity, and

STATEMENT OF RELATED APPLICATIONS This application is the U.S. National Phase under Chapter II of the Patent Cooperation Treaty (PCT) of PCT International Application No. PCT/BR2008/000028 having an International Filing Date of 30 Jan. 2008, which claims priority on Brazilian Patent Application No.

FIELD OF THE INVENTION The invention is related to the adjunctive use of one or more antihypertensive drugs (e.g., preferably calcium channel blockers or beta blockers) to ameliorate drug-induced elevations in blood pressure which are symptomatic of stimulant, analgesic, and antipyretic therapies.